System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Xiaoxin Hao is an expert in Oncology at Baylor College of Medicine (United States). Xiaoxin Hao has authored 25 publications, the most recent in 2025. SLR score: 86 (community average: 125). How the SLR is computed.

LeadR Profile

Xiaoxin Hao Baylor College of Medicine United States
86 ScienceLeadR Reputation 86

Unlock

Register Login
Network Map

Oncology

Subspecialties: Genetics - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Short Biography

Dr. Xiaoxin Hao received his Ph.D. from Shanghai Jiao Tong University School of Medicine, where he investigated the role of bone marrow niches in regulating hematopoiesis and leukemia development. From 2019 to 2024, he completed postdoctoral training in the laboratory of Dr. Xiang Zhang at Baylor College of Medicine (Houston), focusing on how solid tumors remodel the bone marrow hematopoietic ecosystem. In 2024, Dr. Hao joined the Chinese Academy of Medical Sciences & Peking Union Medical College as an independent Principal Investigator and tenure-track Assistant Professor. The Hao Lab is dedicated to studying tumor-hematopoietic regulation and systemic effects, aiming to systematically dissect this interaction and develop new targeting strategies.

Organizations

Career arc: 2019 - 2026
Source: PubMed

Baylor College of Medicine

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 25

Citations

Citations: 597 1st author: 4 Last author: 0 Unique author: 0

Main journals

J Clin Invest 3
Blood 2
Cancer Discov 2
bioRxiv 2
Adv Exp Med Biol 1

Best Journals

Cell 1
Immunity 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Single-cell profiling of bone metastasis ecosystems from multiple cancer types reveals convergent and divergent mechanisms of bone colonization.
PMID 40412393 — cells, neoplasms, ecosystem, neoplasm metastasis, tissues, immunosuppression therapy, tumor microenvironment, immune evasion		Cell Genom20250
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer.
PMID 40157359 — cells, extracellular vesicles, triple negative breast neoplasms, breast neoplasms, arachidonic acid, neoplasms, neutrophils, drug therapy, immunotherapy, breast, therapeutics, fatty acids, chemotherapy		Immunity Top journal20250
Bone-Induced HER2 Promotes Secondary Metastasis in HR+/HER2- Breast Cancer.
PMID 39835789 — breast neoplasms, neoplasms, neoplasm metastasis, breast		Cancer Discov20251
Multiscale 3D spatial analysis of the tumor microenvironment using whole-tissue digital histopathology.
PMID 39749685 — neoplasms, tissues, tumor microenvironment, spatial analysis		Cancer Commun (Lond)20250
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactions.
PMID 39266726 — cells, cell biology, myeloid cells, cell communication, immunosuppression therapy, b-lymphocytes		Nat Cell Biol202415

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS